One of those vulnerabilities, in line with the proteasome inhibitor-induced prolonged depletion of intracellular amino acids, is that some MM cells depended on GCN2, the only kinase known to be activated by low amino acid levels (48–50), to recover from proteasome inhibition. This evidence concerns the gene EIF2AK4 and Miyoshi myopathy.